RecruitingNCT03001180

Identification of Biomarkers for Patients with Vascular Anomalies

Sponsor

Children's Hospital Medical Center, Cincinnati

Enrollment

1,000 participants

Start Date

Apr 1, 2015

Study Type

OBSERVATIONAL

Conditions

Vascular Anomaly Klippel Trenaunay Syndrome Kaposiform Hemangioendothelioma Generalized Lymphatic Anomaly Kaposiform Lymphangiomatosis Gorham-Stout Disease Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi

Summary

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.

Eligibility

Min Age: 1 Day

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with congenital lipomatous overgrowth, vascular malformations, and epidermal nevi, generalized lymphatic anomaly, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 1 Day and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.